Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

Lobbying for governments in Brussels

Lobbying for governments in Brussels: a lucrative business still under the radarThis report presents 15 recent examples of governments using lobby consultancies to influence the EU institutions, including Belarus, Botswana, Ethiopia, Jersey, Kazakhstan and Sri Lanka. They all have hired “public affairs” firms in Brussels to try and boost their diplomacy work. Their motives differ, but include polishing their image, gaining political support, securing EU funding or preferential trade treatment, and blocking new EU regulations.Fifteen examples of national governments using lobbyists to make their case in Brussels.
Lobbying for governments in Brussels: a lucrative business still under the radar
  • Dansk
  • Nederlands
  • English
  • Suomi
  • Français
  • Deutsch
  • Ελληνικά
  • Italiano
  • Bokmål
  • Polski
  • Portuguese
  • Română
  • Slovenščina
  • Español
  • Svenska
This report from Corporate Europe Observatory presents 15 recent examples of governments using lobby consultancies to influence the EU institutions, including Belarus, Botswana, Ethiopia, Jersey, Kazakhstan and Sri Lanka. They all have hired “public affairs” firms in Brussels to try and boost their diplomacy work. Their motives differ, but include polishing their image, gaining political support, securing EU funding or preferential trade treatment, and blocking new EU regulations. This report is probably the most comprehensive overview yet of this little-known part of Brussels lobbying, yet these examples are only the tip of the iceberg. Secrecy among both embassies and consultancies keeps much of this phenomenon out of public sight. Some of the consultancies are lobbying on behalf of governments which are directly or indirectly responsible for serious human rights violations. For instance Bell Pottinger has since 2005 lobbied the EU institutions on behalf of Sri Lanka, whose government is accused of systematic human rights violations. The consultancies lobbying for governments such as Belarus, Botswana, Ethiopia and Kazakhstan, appears not to screen the ethics of their clients. This makes the claims in the codes of conduct of lobbyists associations SEAP and EPACA of operating to the “highest ethical standards” seem rather hollow. Read the full report here:
 

A crusade for big business-friendly deregulation, waged during José Manuel Barroso's Presidency of the European Commission, shows no signs of stopping. This neoliberal push to weaken or block new legislation appears likely to expand with Jean-Claude Juncker's new Commission team.
Our correspondence with Pr. Anne Glover, the current Chief Scientific Adviser to the President of the European Commission (CSA), on her role in the European Commission's review of endocrine disrupting chemicals shows how the very existence of her position was used by business-friendly interests to convey key messages to the top of the European Commission's hierarchy, playing a determining role in the massive delay now inflicted to the European Commission's handling of this important public health regulation. We ask that the CSA position is not renewed in the new Juncker Commission.
Corporate Europe Observatory (CEO) today criticised the plenary vote of MEPs to approve the Jean-Claude Juncker Commission.
CEO just responded to the European Ombudsman’s public consultation on transparency in the negotiations over the Transatlantic Trade and Investment Partnership (TTIP), outlining suggestions for ending the secrecy in the EU-US trade talks.
A crusade for big business-friendly deregulation, waged during José Manuel Barroso's Presidency of the European Commission, shows no signs of stopping. This neoliberal push to weaken or block new legislation appears likely to expand with Jean-Claude Juncker's new Commission team.
Our correspondence with Pr. Anne Glover, the current Chief Scientific Adviser to the President of the European Commission (CSA), on her role in the European Commission's review of endocrine disrupting chemicals shows how the very existence of her position was used by business-friendly interests to convey key messages to the top of the European Commission's hierarchy, playing a determining role in the massive delay now inflicted to the European Commission's handling of this important public health regulation. We ask that the CSA position is not renewed in the new Juncker Commission.
Will EFSA become more transparent, and to lobbyists or scientists? After its public consultation on its draft transparency policy, the Authority must now choose.
Corporate Europe Observatory (CEO) today criticised the plenary vote of MEPs to approve the Jean-Claude Juncker Commission.

Corporate Europe Forum